Brent Hatzis-schoch - Net Worth and Insider Trading
Brent Hatzis-schoch Net Worth
The estimated net worth of Brent Hatzis-schoch is at least $114,287 dollars as of 2024-05-20. Brent Hatzis-schoch is the Sr. VP, General Counsel of Radius Health Inc and owns about 2,278 shares of Radius Health Inc (RDUS) stock worth over $73,967. Brent Hatzis-schoch is also the See Remarks of Black Diamond Therapeutics Inc and owns about 8,400 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $40,320. Details can be seen in Brent Hatzis-schoch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brent Hatzis-schoch has not made any transactions after 2021-05-12 and currently still holds the listed stock(s).
Transaction Summary of Brent Hatzis-schoch
Brent Hatzis-schoch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brent Hatzis-schoch owns 2 companies in total, including Black Diamond Therapeutics Inc (BDTX) , and Radius Health Inc (RDUS) .
Click here to see the complete history of Brent Hatzis-schoch’s form 4 insider trades.
Insider Ownership Summary of Brent Hatzis-schoch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2021-05-12 | See Remarks |
| RDUS | Radius Health Inc | 2017-11-10 | Senior VP and General Counsel |
Brent Hatzis-schoch Latest Holdings Summary
Brent Hatzis-schoch currently owns a total of 2 stocks. Among these stocks, Brent Hatzis-schoch owns 2,278 shares of Radius Health Inc (RDUS) as of November 10, 2017, with a value of $73,967 and a weighting of 64.72%. Brent Hatzis-schoch also owns 8,400 shares of Black Diamond Therapeutics Inc (BDTX) as of May 12, 2021, with a value of $40,320 and a weighting of 35.28%.
Latest Holdings of Brent Hatzis-schoch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RDUS | Radius Health Inc | 2017-11-10 | 2,278 | 32.47 | 73,967 |
| BDTX | Black Diamond Therapeutics Inc | 2021-05-12 | 8,400 | 4.80 | 40,320 |
Holding Weightings of Brent Hatzis-schoch
Brent Hatzis-schoch Form 4 Trading Tracker
According to the SEC Form 4 filings, Brent Hatzis-schoch has made a total of 0 transactions in Radius Health Inc (RDUS) over the past 5 years. The most-recent trade in Radius Health Inc is the acquisition of 1,778 shares on November 10, 2017, which cost Brent Hatzis-schoch around $49,944.
According to the SEC Form 4 filings, Brent Hatzis-schoch has made a total of 10 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 4,078 shares on May 12, 2021, which brought Brent Hatzis-schoch around $111,819.
Insider Trading History of Brent Hatzis-schoch
- 1
Brent Hatzis-schoch Trading Performance
GuruFocus tracks the stock performance after each of Brent Hatzis-schoch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brent Hatzis-schoch is 7.94%. GuruFocus also compares Brent Hatzis-schoch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brent Hatzis-schoch within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brent Hatzis-schoch's insider trading performs compared to the benchmark.
Performance of Brent Hatzis-schoch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.3 | | | | | |
| Relative Return to S&P 500(%) | -1.86 | | | | | |
Brent Hatzis-schoch Ownership Network
Brent Hatzis-schoch Owned Company Details
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Brent Hatzis-schoch is the See Remarks of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , director & 10 percent owner Ali Behbahani , and director & See Remarks David M. Epstein .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Brent Hatzis-schoch made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,132,213 shares were bought by its insiders, resulting in a net purchase of 5,107,213 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
Brent Hatzis-schoch Mailing Address
Above is the net worth, insider trading, and ownership report for Brent Hatzis-schoch. You might contact Brent Hatzis-schoch via mailing address: C/o Radius Health, Inc., 950 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
